FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Deferoxamine Mesylate for Injection, USP
Status: Resolved
»Duration of Shortage: 02/02/2018 - 09/10/2019
»Therapeutic Categories: Hematology

Expand all

ApoPharma USA, Inc. (Revised 09/10/2019)

Company Contact Information:
866-931-0740

Presentation
  • 500 mg per vial, Single use vial, Carton of 4 vials (NDC 52609-4505-6)
  • 2 g per vial, Single use vial, Carton of 4 vials (NDC 52609-4504-6)
Note:
  • N/A

Fresenius Kabi USA, LLC (Revised 09/10/2019)

Company Contact Information:
888-386-1300

Presentation
  • 500 mg per vial, 10 mL vial (NDC 63323-597-10)
Note:
  • N/A

Hospira, Inc. (Revised 09/10/2019)

Company Contact Information:
844-646-4398

Presentation
  • 500 mg; Single Dose Glass Fliptop Vial (NDC 00409-2336-10)
  • 2 g; Single Dose Glass Fliptop Vial (NDC 00409-2337-25)
Note:
  • N/A

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English